The emerging approach of the medication represents a major advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide022096.vidublog.com/40657723/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment